| Uzbekistan | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 108.1 (2020) [159/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 2.8 (2020) [109/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 4.2 (2020) [58/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 26.4 (2020) [157/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 11.0 (2020) [117/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 7.5 (2020) [115/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 4.3 (2020) [119/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.3 (2020) [144/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 2.3 (2020) [103/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 0.7 (2020) [156/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 3.5 (2020) [131/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 3.3 (2020) [55/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 6.0 (2020) [78/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 8.5 (2020) [114/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 1.7 (2020) [159/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 0.1 (2020) [176/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.6 (2020) [58/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 3.2 (2020) [160/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 5.1 (2020) [32/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.9 (2020) [64/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 4.5 (2020) [138/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 3.0 (2020) [112/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 8.5 (2020) [166/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 9.8 (2020) [43/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 1.5 (2020) [82/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 1.2 (2020) [148/184countries] | | |
|
| Uzbekistan | | |
Suicide, age-standardized (per 100 000 population) | 8.28 (2019) [90/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 11.84 (2019) [104/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 4.93 (2019) [73/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 14.09 (2019) [20/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 14.58 (2019) [43/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 13.59 (2019) [8/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 9.27 (2019) [65/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 12.96 (2019) [78/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 5.49 (2019) [42/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 11.48 (2019) [69/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 18.50 (2019) [69/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 4.61 (2019) [70/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 10.74 (2019) [102/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 18.76 (2019) [94/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 3.28 (2019) [124/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 8.23 (2019) [131/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 14.83 (2019) [123/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 2.40 (2019) [141/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 8.12 (2019) [135/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 13.57 (2019) [131/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 3.62 (2019) [132/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 8.73 (2019) [143/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 12.94 (2019) [147/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 5.69 (2019) [120/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 15.25 (2019) [136/183countries] | | |
|
|